Month: December 2017

Denali Therapeutics #IPO Preview $DNLI

Company: Denali Therapeutics Inc Symbol: DNLI Description: Their goal is to discover and develop therapeutics to defeat degeneration. Shares: 8.33 million Price Range: $17.00-$19.00 Trade Date: 12/8 Underwriter(s): Goldman Sachs, J.P. Morgan, Morgan Stanley Co-Manager(s): Evercore ISI Filed: 11-27-17 Link to S-1/A Prospectus Link to Retail Roadshow Business: Their total portfolio currently consists of eleven programs.[…]

Scroll to top
error: Content is protected !!